The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
  • Ticker

RNS




GlaxoSmithKline PLC - GSK GSK files closed triple therapy for COPD in EU
14:19 02-Dec-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK Relvar Ellipta approved in Japan for COPD
07:01 02-Dec-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK EU submission of shingles candidate vaccine
13:35 25-Nov-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK Start of Phase III studies with daprodustat
11:07 24-Nov-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK Mepolizumab meets endpoints in phase 3 EGPA study
07:05 23-Nov-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK GSK files closed triple therapy for COPD in US
07:02 21-Nov-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK ViiV starts PhIII LA injectable treatment regimen
14:40 18-Nov-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK New phase III data of sirukumab for RA
16:04 16-Nov-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK GSK issues new data on shingles candidate vaccine
12:06 27-Oct-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK Second Price Monitoring Extn
12:07 26-Oct-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK Price Monitoring Extension
12:02 26-Oct-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK 3rd Quarter Results
12:00 26-Oct-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK US FDA submission of shingles candidate vaccine
07:00 24-Oct-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK GSK completes sale of holding in Aspen
07:54 29-Sep-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK GSK intends to sell remaining holding in Aspen
16:19 28-Sep-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK US Regulatory Submission for sirukumab in RA
13:00 23-Sep-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK GSK Appoints New CEO
07:00 20-Sep-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK Results Phase III Study Shingrix Vaccine in NEJM
07:00 15-Sep-2016  RNS  1.23% View chart
GlaxoSmithKline PLC - GSK EU regulatory submission for sirukumab in RA
12:33 12-Sep-2016  RNS  1.23% View chart


RNS - regulatory news service - home


MARKET NEWS – SEARCH FEATURES

Market News is the definitive place to view real-time UK regulatory disclosures.

You will see a clear and comprehensive search, filter and sort features giving users the ability to:

  • Show only Earnings and News announcements - the default search
  • Show all announcements excluding NAVs & FRNs
  • Show all announcement types
  • See up to 500 stories per page
  • See ‘Most read news’ ticker at the top of the page
  • Select stories by Name/code, source, type, index or sector


about rns

 

News Sources

For information about RNS reach and News Announcements, the news sources available within the Market news section.



rssRNS feeds
Allows you to be kept updated with RNS announcements.


The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds